Search research articles
Contact Us
Filters
Showing results (41-50 of 81) with videos related to
Page
of 9
Sort By:
Journal of Cellular and Molecular Medicine
|
June 20, 2025
Signalling Network Analysis of Blood Mononuclear Cells From Clinical Samples by Bivariate Correlation
David Kaplan, Hillard M Lazarus, Jason Valent, et al.
Hematological Oncology
|
April 13, 2025
Presentation and Outcomes of Localized Immunoglobulin Light Chain Amyloidosis: 14-Year Experience of an Academic Center
Danai Dima, Utkarsh Goel, Fauzia Ullah, et al.
Journal of Cellular and Molecular Medicine
|
September 22, 2025
Molecular Expression Differences in Specific Blood Mononuclear Cell-Types Identify Patients With AL Amyloidosis
David Kaplan, Eric Christian, Jason Valent, et al.
Plos One
|
March 10, 2017
Neuropathy and efficacy of once weekly subcutaneous bortezomib in multiple myeloma and light chain (AL) amyloidosis
Surbhi Sidana, Mayur Narkhede, Paul Elson, et al.
British Journal of Haematology
|
January 6, 2023
External validation of the SAVED score for venous thromboembolism risk stratification in patients with multiple myeloma receiving immunomodulatory drugs
Danai Dima, Ang Li, Lauren M Granat, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
April 18, 2013
Evaluating the effects of lenalidomide induction therapy on peripheral stem cells collection in patients undergoing autologous stem cell transplant for multiple myeloma
Divaya Bhutani, Jeffrey Zonder, Jason Valent, et al.
Cancers
|
May 27, 2026
Smoldering Multiple Myeloma: Early Intervention or Structured Surveillance? A Comprehensive Review of Evidence for and Against Early Therapy
Kirti Arora, Lara Soueid, Louis Williams, et al.
Bone Marrow Transplantation
|
February 24, 2023
On demand plerixafor is safe and effective for hematopoietic progenitor cell mobilization in patients with light chain amyloidosis at risk for mobilization failure with G-CSF alone
Anne Hubben, Danai Dima, Tahani Atieh, et al.
Transplantation and Cellular Therapy
|
December 24, 2023
Impact of Frailty on Outcomes after Chimeric Antigen Receptor T Cell Therapy for Patients with Relapsed/Refractory Multiple Myeloma
James A Davis, Danai Dima, Nausheen Ahmed, et al.
American Journal of Hematology
|
January 22, 2019
Progression with clinical features is associated with worse subsequent survival in multiple myeloma
Rajshekhar Chakraborty, Hien D Liu, Lisa Rybicki, et al.
Page
of 9
Search research articles
Search
Showing results (41-50 of 81) with videos related to
Sort By:
Page
of 9
Journal of Cellular and Molecular Medicine
|
June 20, 2025
Signalling Network Analysis of Blood Mononuclear Cells From Clinical Samples by Bivariate Correlation
David Kaplan, Hillard M Lazarus, Jason Valent, et al.
Hematological Oncology
|
April 13, 2025
Presentation and Outcomes of Localized Immunoglobulin Light Chain Amyloidosis: 14-Year Experience of an Academic Center
Danai Dima, Utkarsh Goel, Fauzia Ullah, et al.
Journal of Cellular and Molecular Medicine
|
September 22, 2025
Molecular Expression Differences in Specific Blood Mononuclear Cell-Types Identify Patients With AL Amyloidosis
David Kaplan, Eric Christian, Jason Valent, et al.
Plos One
|
March 10, 2017
Neuropathy and efficacy of once weekly subcutaneous bortezomib in multiple myeloma and light chain (AL) amyloidosis
Surbhi Sidana, Mayur Narkhede, Paul Elson, et al.
British Journal of Haematology
|
January 6, 2023
External validation of the SAVED score for venous thromboembolism risk stratification in patients with multiple myeloma receiving immunomodulatory drugs
Danai Dima, Ang Li, Lauren M Granat, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
April 18, 2013
Evaluating the effects of lenalidomide induction therapy on peripheral stem cells collection in patients undergoing autologous stem cell transplant for multiple myeloma
Divaya Bhutani, Jeffrey Zonder, Jason Valent, et al.
Cancers
|
May 27, 2026
Smoldering Multiple Myeloma: Early Intervention or Structured Surveillance? A Comprehensive Review of Evidence for and Against Early Therapy
Kirti Arora, Lara Soueid, Louis Williams, et al.
Bone Marrow Transplantation
|
February 24, 2023
On demand plerixafor is safe and effective for hematopoietic progenitor cell mobilization in patients with light chain amyloidosis at risk for mobilization failure with G-CSF alone
Anne Hubben, Danai Dima, Tahani Atieh, et al.
Transplantation and Cellular Therapy
|
December 24, 2023
Impact of Frailty on Outcomes after Chimeric Antigen Receptor T Cell Therapy for Patients with Relapsed/Refractory Multiple Myeloma
James A Davis, Danai Dima, Nausheen Ahmed, et al.
American Journal of Hematology
|
January 22, 2019
Progression with clinical features is associated with worse subsequent survival in multiple myeloma
Rajshekhar Chakraborty, Hien D Liu, Lisa Rybicki, et al.
Page
of 9